ND
Neurum Diabetic Care Center at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Neurum Diabetic Care Center brings 3 presentations to ESGCT 2026 in Hamburg. Its work reviews the clinical evidence for cell therapy in diabetes. The reviews weigh efficacy and safety for mesenchymal stromal cell treatment across type 1 and type 2 diabetes and their complications, and for stem-cell-derived islet replacement.
| Organization | ESGCT 2026 Attendance |
|---|---|
ND Neurum Diabetic Care Center Medellín, Colombia | |
Poster Wed Oct 28 1:30pm–3:30pm Clinical efficacy of mesenchymal stromal cell-based therapy across type 1 diabetes, type 2 diabetes and diabetic complications: a systematic review Poster Wed Oct 28 1:30pm–3:30pm Stem-cell-derived islet replacement and non-MSC stem-cell-based therapies across diabetes mellitus and diabetic complications: a systematic review about clinical efficacy Cell therapies and CAR-T Poster Thu Oct 29 2:00pm–4:00pm Clinical safety of stem-cell-derived islet replacement and non-MSC stem-cell-based therapies across diabetes mellitus and diabetic complications: a systematic review Cell therapies and CAR-TClinical trials and translation |
Instantly find 20 buyers from Neurum Diabetic Care Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction